QINLOCK

Product Overview

About QINLOCK

QINLOCK is a medicine that contains the active ingredient RIPRETINIB, used for the treatment of certain medical conditions. It is specifically designed to target and inhibit specific proteins that can lead to disease progression. QINLOCK is administered orally and is intended for patients who have been diagnosed with a particular type of gastrointestinal stromal tumor (GIST) that has been previously treated with other therapies.

Key Benefits & Uses

• Treatment of adult patients with advanced GIST who have received prior treatment with certain other therapies
• Targeted therapy that inhibits specific proteins involved in tumor growth and progression
• Oral administration for convenient dosing and management of treatment

Active Ingredient & Action

RIPRETINIB, the active ingredient in QINLOCK, works by selectively inhibiting certain proteins, including KIT and PDGFRA, which are involved in the growth and proliferation of cancer cells. By blocking these proteins, RIPRETINIB helps to slow down or stop the growth of tumors, leading to improved treatment outcomes for patients with advanced GIST.

Important Notes

Patients should take QINLOCK exactly as prescribed by their healthcare provider, and report any side effects or concerns promptly. It is essential to follow the recommended dosage and administration schedule to ensure optimal treatment outcomes and minimize potential risks. As with any medication, QINLOCK may have side effects, and patients should discuss these with their healthcare provider before starting treatment.